The news of a multi-year sales deal has caused shares of Rockwell Medical, Inc. (NASDAQ: RMTI) to jump noticeably on the charts. The pre-market session as of the last check, saw RMTI shares rise 16.92% to $2.35. Investor confidence in the company’s strategic efforts and market presence is reflected in this upswing.
Important Deal with World Dialysis Leader
Rockwell Medical has inked a deal to sell items to a major worldwide supplier of dialysis supplies and services. Being the leading supplier of liquid bicarbonate in the US, Rockwell Medical is in a unique position since no other company can produce liquid bicarbonate on a large enough scale to satisfy the needs of the country’s largest dialysis providers.
For a three-year initial agreement, with the possibility of two one-year extensions, RMTI will provide its SteriLyte liquid bicarbonate hemodialysis concentrates. Over $10 million in net sales are predicted in the first year of the arrangement, with more price hikes likely in the following years.A portion of this revenue was not included in previously disclosed estimates for 2025, indicating additional growth potential.
Partnership with HydroCare Expands Product Reach
In a separate development, RMTI has partnered with HydroCare, a global leader in dialysis water treatment systems. This collaboration focuses on installing Rockwell Medical’s DAMX45 dry acid concentrate mix system in dialysis water rooms. The system, which is FDA 510(k)-approved, works seamlessly with the company’s CitraPure and Dri-Sate dry acid concentrates.
The DAMX45 mixer enables clinics to prepare 100 gallons of acid concentrate on-site in just three minutes, significantly improving efficiency. HydroCare recognized the system’s reliability and ease of use, making it an ideal choice for enhancing dialysis water room operations. This partnership provides Rockwell Medical with a pathway to extend its market reach and benefit more patients globally.
A Commitment to Advancing Dialysis Care
These tactical partnerships highlight Rockwell Medical’s commitment to providing cutting-edge solutions that enhance patient care. RMTI is ideally positioned for long-term growth in the dialysis industry because to its robust market presence and cutting-edge product offerings.
